English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma

Rothe, A., Jachimowicz, R. D., Borchmann, S., Madlener, M., Keßler, J., Reiners, K. S., et al. (2014). The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma. International Journal of Cancer, 134(12), 2829-2840. doi:10.1002/ijc.28609.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Rothe, Achim1, Author
Jachimowicz, Ron D.1, Author
Borchmann, Sven1, Author
Madlener, Marie1, Author
Keßler, Jörg1, Author
Reiners, Katrin S.1, Author
Sauer, Maike1, Author
Hansen, Hinrich P.1, Author
Ullrich, Roland T.2, Author           
Chatterjee, Sampurna3, Author           
Borchmann, Peter1, Author
Yazaki, Paul1, Author
Koslowsky, Thomas C.1, Author
Engert, Andreas1, Author
Heukamp, Lukas C.1, Author
Hallek, Michael1, Author
Von Strandmann, Elke Pogge1, Author
Affiliations:
1a Department I of Internal Medicine, Innate Immunity Group University Hospital Cologne Cologne Germany b Center of Molecular MedicineCologne Germany c Department I of Internal Medicine, German Hodgkin Study Group (GHSG)University Hospital Cologne Cologne Germany d Department of Cancer Immunotherapeutics and Tumor Immunology Beckman Research Institute of the City of Hope Duarte, CA e Department of SurgerySt. Elisabeth Hospital Cologne Germany f Department for Pathology University Hospital Cologne Cologne Germany g Center of Integrated Oncology, ColgneBonn Germany, ou_persistent22              
2Klinisches PET, Neurologische Abteilung, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149663              
3In-vivo-NMR, Research Groups, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149666              

Content

show
hide
Free keywords: -
 Abstract: © 2013 UICC.

Details

show
hide
Language(s): eng - English
 Dates: 2014
 Publication Status: Published in print
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: eDoc: 671192
DOI: 10.1002/ijc.28609
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: International Journal of Cancer
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 134 (12) Sequence Number: - Start / End Page: 2829 - 2840 Identifier: ISSN: 00207136